Risk of Heart Failure Higher for Patients with Rheumatoid Arthritis
Heart failure higher among RA patients independent of their risk for ischemic heart disease.
Patients with rheumatoid arthritis (RA) have an increased risk of heart failure independent of their increased risk of ischemic heart disease.
In a
The investigators identified 2 contemporary cohorts of RA subjects from Swedish patients and rheumatology registries, and matched 1:10 to general population comparator subjects. Through registry linkages, a first-ever heart failure diagnosis was assessed—–classified as ischemic heart failure or nonischemic heart failure—based on the presence of ischemic heart disease.
The results of the study showed that at the time of RA onset, a history of heart failure was not more common in RA. The overall HRs for subsequent heart failure (any type), ischemic heart failure, and non-ischemic heart failure were between 1.22 and 1.27 among new-onset RA patients.
The investigators observed a rapid increase in the risk of non-ischemic heart failure after onset of RA, in contrast to the risk of ischemic
Although the investigators found an association between high disease activity and all heart failure types, it was most pronounced for non-ischemic heart failure.
The HRs among the different heart failure subtypes were between 1.71 and 1.88 in the cohort of patients with RA of any duration, according to the study.
“Patients with RA are at increased risk of heart failure that cannot be explained by their increased risk of ischemic heart disease,” the authors wrote. “The increased risk of non-ischemic heart failure occurred early and was associated with RA severity.”
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025